Skip to main content

Table 1 Characteristics of study participants

From: New evidences on the altered gut microbiota in autism spectrum disorders

  Autistic Neurotypical
Subjects (n) 40 40
Age (1st–3rd quartile) 10 (5–17) 7 (3.6–12)
Gender (n)
 Female 22.5% (9) 30% (12)
 Male 77.5% (31) 70% (28)
Constipation (n)
 Constipated 12.5% (5) 27.5% (11)
 Non-constipated 72.5% (29) 72.5% (29)
 NA 15% (6) 0% (0)
Calprotectin (1st–3rd quartile) 36.9 (17.6–76.0) μg/g 40.9 (17–74.7) μg/g
 Constipated 39.1 (22.9–70.0) μg/g 27.9 (20.3–97.6) μg/g
 Non-constipated 35.9 (15.0–57.8) μg/g 50.5 (15.0–73.8) μg/g
CARS (1st–3rd quartile) 47 (40–50.5) NA
 Constipated 50 (36–52.0) NA
 Non-constipated 48 (42–50.0) NA
ESR (1st–3rd quartile) 7.5 (3.25–17.7) mm/h NA
 Constipated 22.0 (12.0–25.0) mm/h NA
 Non-constipated 7.0 (2.7–11.2) mm/h NA
Serum IgA (1st–3rd quartile) 131.0 (70.0–172.2) mg/ml NA
 Constipated 97.0 (82.0–153.0) mg/ml NA
 Non-constipated 133.0 (67.0–181.0) mg/ml NA
  1. Data expressed as medians with interquartile ranges when applicable. AD autistic subjects, NT neurotypical subjects, NA not applicable, CARS Childhood Autism Rating Scale, ESR erythrocyte sedimentation rate